Catalyst Pharmaceuticals (CPRX) Current Taxes (2023 - 2026)

Catalyst Pharmaceuticals (CPRX) has 4 years of Current Taxes data on file, last reported at $19.6 million in Q1 2026.

• Quarterly Current Taxes rose 77.02% year-over-year to $19.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (up 77.02% YoY) and the FY2025 annual result came in at $1.4 million, up 56.15% from the prior year.
• Current Taxes grew to $19.6 million in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $19.6 million in Q1 2026 to a low of $15000.0 in Q2 2024.
• A 4-year average of $4.4 million and a median of $811500.0 in 2023 frame the typical range for Current Taxes.
• Annual changes were most pronounced in 2024 — Current Taxes grew 22.63% — and 2025, when it surged 2826.67%.
• Tracing CPRX's Current Taxes over 4 years: stood at $729000.0 in 2023, then gained by 22.63% to $894000.0 in 2024, then soared by 56.15% to $1.4 million in 2025, then jumped by 1305.87% to $19.6 million in 2026.
• The last three Current Taxes figures came in at $19.6 million (Q1 2026), $1.4 million (Q4 2025), and $710000.0 (Q3 2025), per Business Quant data.